Tag: Oral Health Award

Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Prof. Dr. Gianna Dipalma | Medicine and Dentistry | Research Excellence Award

University of Bari “Aldo Moro” – University Hospital “Policlinico di Bari” | Italy

Prof. Gianna DiPalma is an accomplished clinician-scientist and academic specializing in dentistry, oral surgery, orthodontics, and regenerative medicine. With dual qualifications in Dentistry (DDS, 2000) and Medicine and Surgery (MD, 2020) from the University of Bari “Aldo Moro,” she has established a distinguished career bridging clinical practice, scientific innovation, and higher education. She further completed an international PhD program in Clinical Dentistry, conducted in collaboration with New York University (USA) and the Eastman Dental Institute (UK), followed by advanced postgraduate training in implant prosthodontics and oral surgical specialization. Her academic trajectory includes an international doctoral fellowship at the University of Lyon, France, reinforcing her international scientific profile. Prof. DiPalma has contributed extensively to oral health sciences, with research spanning regenerative dentistry, biomaterials, implantology, growth factor–based tissue repair, pediatric dentistry, and digital orthodontics. She has authored scientific publications, book chapters, and conference works, and serves as a reviewer and guest editor for internationally indexed journals, including Scopus- and PubMed-listed platforms. Her research involvement includes participation in competitive national and international projects, particularly those focusing on tissue engineering, stem cells, and translational dentistry. Her work demonstrates significant interdisciplinary relevance across dental medicine, biomedical engineering, and clinical innovation. Throughout her career, she has received more than 30 national and international awards recognizing academic merit, research contribution, and innovation in clinical dentistry. She has also contributed to the advancement of dental education through extensive teaching roles, postgraduate training supervision, and invited lectures across Europe and beyond. Prof. DiPalma’s contributions continue to support evidence-based innovations that improve patient care, guide clinical protocols, and enhance the global development of regenerative and digital dental sciences. Her academic trajectory reflects sustained research productivity, international collaboration, and a growing societal impact within the fields of oral health and medical sciences.

Profiles: Scopus | ORCID

Featured Publications

Buthelezi, K., Kibirige, D. M. K., & Buthelezi-Dube, N. N. (2025). The evolution of methods and tools used to assess soil health indicators: A scoping review. SSRN.

Buthelezi-Dube, N. N., & Sithole, Z. (2025). Acidification-driven soil phosphorus fractionation following long-term fertilization and cessation at Ukulinga mesic grassland in South Africa. Scientific Reports.

Buthelezi, K., & Buthelezi-Dube, N. (2025). Long-term effects of nitrogen and lime application on plant–microbial interactions and soil carbon stability in a semi-arid grassland. Plants.

Leshalagae, M., & Buthelezi-Dube, N. N. (2023). Impact of topsoil mining for unfired mudbricks on soil quality in eastern KwaZulu-Natal, South Africa. Land Degradation & Development.

Vilakazi, S. P., Muchaonyerwa, P., & Buthelezi-Dube, N. N. (2023). Characteristics and liming potential of biochar types from potato waste and pine-bark. PLOS ONE

Ahmed A Holiel | Dentistry | Research Excellence Award

Published on by WSA Awards

Assist. Prof. Dr. Ahmed A Holiel | Dentistry | Research Excellence Award

Alexandria University, Beirut Arab University | Egypt

Assist. Prof. Dr. Ahmed A. Holiel is an accomplished academic and clinician specializing in Restorative and Esthetic Dentistry, with a core research focus on biomaterials, pulp regeneration, digital dentistry, and adhesive restorative systems. He earned his Bachelor’s degree with honors from the Faculty of Dentistry, Alexandria University, followed by a Master’s and Ph.D. in Restorative & Esthetic Dentistry from the same institution. Notably, he became the first researcher at Alexandria University’s Faculty of Dentistry to be exempted from Ph.D. thesis defense after publishing two articles in top-tier ISI journals. Dr. Holiel has progressed through a solid academic career pathway, beginning as a Demonstrator and later assuming roles as Assistant Lecturer and Lecturer at Alexandria University. He currently serves as an Assistant Professor of Restorative & Esthetic Dentistry at Beirut Arab University, Lebanon. He has also contributed internationally as a visiting lecturer at multiple institutions, including the Arab Academy for Science, Technology & Maritime Transport. His contributions to research are significant, with numerous peer-reviewed publications in well-recognized journals covering tissue engineering, biomimetic materials, laser dentistry, pulp regeneration, and emerging technologies in dental science. His work includes multiple clinical trials, in vitro studies, systematic reviews, meta-analyses, and innovation-driven translational research. He also serves as a peer reviewer for leading scholarly journals and acts as Guest and Lead Editor for notable international journals, demonstrating his expertise and academic leadership. Dr. Holiel’s teaching portfolio includes undergraduate, postgraduate, and international credit-hour programs, with roles as course director and coordinator in various operative and esthetic dentistry modules. His clinical experience extends to digital workflows, CAD/CAM systems, smile design, and laser-assisted restorative procedures. A recipient of several distinctions, including the Egyptian Hatton Award and multiple institutional recognitions, Dr. Holiel is an active member of global professional bodies such as the International Association for Dental Research (IADR) and the Tissue Engineering and Regenerative Medicine Society.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Grawish, M. E., Grawish, L. M., Grawish, H. M., Grawish, M. M., Holiel, A. A., Sultan, N., … (2022). Demineralized dentin matrix for dental and alveolar bone tissues regeneration: An innovative scope review. Tissue Engineering and Regenerative Medicine, 19(4), 687–701.

Holiel, A. A., Mahmoud, E. M., Abdel-Fattah, W. M., & Kawana, K. Y. (2021). Histological evaluation of the regenerative potential of a novel treated dentin matrix hydrogel in direct pulp capping. Clinical Oral Investigations, 25(4), 2101–2112.

Holiel, A. A., Mahmoud, E. M., & Abdel-Fattah, W. M. (2021). Tomographic evaluation of direct pulp capping using a novel injectable treated dentin matrix hydrogel: A 2-year randomized controlled clinical trial. Clinical Oral Investigations, 25(7), 4621–4634.

Morsy, N., & Holiel, A. A. (2023). Color difference for shade determination with visual and instrumental methods: A systematic review and meta-analysis. Systematic Reviews, 12(1), 95.

Abbassy, K. M., Elmahy, W. A., & Holiel, A. A. (2023). Evaluation of the proximal contact tightness in class II resin composite restorations using different contact forming instruments: A 1-year randomized controlled clinical trial. BMC Oral Health, 23(1), 729.

Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Published on by WSA Awards

Mrs. Aurore Sajust de Bergues de Escalup | Medicine and Dentistry | Research Excellence Award

Fondation Adolphe de Rothschild Hospital | France

Dr. Aurore Sajust de Bergues de Escalup is a radiology resident specializing in advanced neuroimaging, thoracic imaging, and musculoskeletal diagnostic modalities, with a growing research portfolio in artificial intelligence–enhanced medical imaging. She is currently completing the advanced phase of her radiology residency at the Hôpital Fondation Adolphe de Rothschild, focusing on neuroradiology and head-and-neck imaging, while simultaneously advancing her research interests in biomedical image analysis and quantitative MRI. Dr. Sajust de Bergues de Escalup holds a Master’s degree in Biomedical Engineering (BioImaging Specialization), awarded with honors, and completed at the PARCC laboratory (Inserm UMR 970). She was awarded the Année Recherche scholarship (ARS), supporting her contributions to translational imaging research. Her academic foundation includes competitive rankings in French national medical examinations (PACES rank: 52; ECN rank: 1227) and early international scientific exposure through her participation in the Biomed Research Academy at the University of Pennsylvania. Her recent peer-reviewed publications reflect an interdisciplinary approach combining clinical expertise and innovation. These include studies on synthetic MRI for optic nerve pathology, deep learning–based MRI reconstruction techniques, and CT phenotypes of interstitial lung disease in autoimmune disorders. Collectively, her work contributes to improving diagnostic accuracy, reducing scan times, and advancing precision imaging in ophthalmologic and thoracic conditions. Her collaborations span multiple major French academic hospitals, including Hôpital Robert-Debré, Hôpital Henri-Mondor, Hôpital Bichat, and the Hôpital de la Timone. Fluent in French and English, she has developed both clinical and research experience across pediatric radiology, emergency imaging, cardiothoracic radiology, and uro-gynecological imaging. Her long-term vision is to contribute to the integration of artificial intelligence and quantitative imaging biomarkers to enhance clinical decision-making and improve patient outcomes in neuroradiology and systemic disease evaluation.

Profile: ORCID

Featured Publications

Sajust de Bergues de Escalup, A., Lecler, A., Poirion, É., Papeix, C., Deschamps, R., Milea, D., Savatovsky, J., Duron, L., & O’Shaughnessy, E. (2025). Deep learning-based image reconstruction significantly improves image quality of MRI examinations of the orbit at 3 Tesla. Diagnostic and Interventional Imaging.

Sajust de Bergues de Escalup, A., Duron, L., Koskas, P., Poirion, É., Papeix, C., Deschamps, R., Milea, D., O’Shaughnessy, E., Savatovsky, J., Fournier, L., et al. (2025). Synthetic MRI for detecting abnormal signals in the optic nerves. Investigative Radiology

Divya Raja | Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Divya Raja | Dentistry | Best Researcher Award

Saveetha dental college and hospital | India

Dr. Divya Raja is an accomplished General Dentist whose career reflects a harmonious blend of clinical expertise, academic engagement, and public health contribution. With over six years of professional experience, she has established herself as a skilled practitioner in restorative, conservative, and surgical dentistry. Having completed her Bachelor of Dental Surgery (BDS) at Sri Venkateshwara Dental College and Hospital, Chennai, she further honed her skills through advanced training at Christian Medical College (CMC), Vellore—earning both a Certificate and a Fellowship in Advanced General Dentistry. Her tenure at CMC, a globally recognized healthcare institution, enabled her to gain extensive experience in managing a wide range of dental and oral health conditions, including root canal therapy, impactions, apicoectomies, cyst enucleations, and maxillofacial emergencies. Beyond clinical practice, Dr. Raja has actively contributed to research and academic discourse. She served as a Clinical Research Officer in the Government of India’s Department of Biotechnology (DBT)-funded project “Genomic Surveillance for SARS-CoV-2 in India (INSACOG)” at CMC Vellore, bridging dentistry with biomedical research and public health genomics. Her publication, “Atypical Presentation of Lobular Capillary Hemangioma of the Maxillary Alveolus: A Case Report” in the Journal of Clinical and Diagnostic Research, showcases her analytical and documentation skills in clinical case reporting. In addition, she has participated in major academic platforms, including the World Dental Congress and the World Head and Neck Cancer Program, demonstrating her commitment to continuing professional development and global knowledge exchange. Dr. Raja’s professional impact extends beyond hospitals and laboratories—she has conducted numerous dental awareness and screening camps in rural communities, promoting preventive oral health care among underserved populations. Her interdisciplinary approach, patient-centered philosophy, and dedication to healthcare advancement underline her role as a promising contributor to the global dental community. With a growing record of research, academic collaboration, and clinical excellence, Dr. Divya Raja continues to embody the ideals of ethical, innovative, and socially responsive dentistry.

Profile: ORCID

Featured Publications

  1. Dr. Divya Raja, Ramasamy, N., Ashok, Y., & Rani, N. (2025). Stability outcomes of internal and external distractors in maxillary distraction osteogenesis for cleft lip and palate: A systematic review. Dentistry Review, 100161.

Johanna Gaß | Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Johanna Gaß | Dentistry | Best Researcher Award

Private Practice, Germany

Dr. Johanna Alexandra Gaß, M.Sc., is an emerging expert in periodontology, implant therapy, and aesthetic restorative dentistry, recognized for her evidence-based approach and scientific precision. She completed her Doctorate in Medicine (magna cum laude) at the University Hospital Heidelberg, where her research focused on the prognostic relevance of genetic signatures in head and neck squamous cell carcinoma—an interdisciplinary study bridging molecular oncology and clinical outcomes. Her academic foundation is strengthened by a Master of Science in “Parodontologie und Implantattherapie” from the Dresden International University (DIU), awarded with highest distinction. Professionally, Dr. Gaß has gained extensive clinical and research experience through her work in leading dental and periodontal practices in Frankfurt and Berlin, combining clinical excellence with innovative methodologies in advanced implantology and minimally invasive periodontal therapy. Dr. Gaß has contributed several peer-reviewed publications in high-impact journals such as International Journal of Cancer and Clinical Advances in Periodontics, alongside conference presentations at prestigious national meetings including the DGParo Annual Congress. Her research on ceramic veneer restorations in periodontally compromised patients and cathepsin-related mechanisms in periodontal disease demonstrates her ability to integrate translational research with clinical applicability. With growing scholarly recognition, her academic output includes multiple collaborative works with leading clinicians and researchers across Germany, emphasizing the importance of interdisciplinary integration between basic science and clinical dentistry. Her research and clinical practice focus on digitalization in dental workflows, regenerative periodontal therapy, and personalized treatment planning—fields central to the modernization of oral healthcare. As a B. Braun Foundation Scholar and Young Speaker for the ARPA Foundation, she has demonstrated leadership and commitment to advancing professional education. Dr. Gaß’s contributions extend beyond the clinic, influencing dental science through research, teaching, and innovation, aimed at improving global oral health outcomes and promoting sustainable, patient-centered dentistry.

Profile: ORCID

Featured Publications

  1. Bäumer, A. M., Riemer, C. T., Büsch, C., Körner, G. A., & Gaß, J. A. (2025). Patient satisfaction among periodontally stable patients with veneer restorations—A retrospective study. Clinical Advances in Periodontics.

  2. Gaß, J. A., Büsch, C., Körner, G. A., & Bäumer, A. M. (2023). Ceramic anterior veneer restorations in periodontally compromised patients: A retrospective study. Clinical Advances in Periodontics.

  3. Plath, M., Gaß, J., Hlevnjak, M., Li, Q., Feng, B., Pastor Hostench, X., Bieg, M., Schroeder, L., Holzinger, D., Zapatka, M., et al. (2021). Unraveling most abundant mutational signatures in head and neck cancer. International Journal of Cancer, 148(1).

Dr. Johanna Gaß’s work bridges scientific research and clinical innovation in periodontology and implant therapy, advancing evidence-based, minimally invasive treatments that enhance long-term oral health outcomes. Her integration of digital dentistry, regenerative approaches, and translational research fosters global progress toward personalized, sustainable, and patient-centered dental care.

Maria Sundvall | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Maria Sundvall | Medicine and Dentistry | Best Researcher Award

University of Turku, Finland

Dr. Maria Sundvall is a distinguished physician-scientist and academic leader in Clinical Oncology and Molecular Cancer Biology, renowned for her translational research bridging laboratory discoveries with clinical applications. She earned her Medical Doctor degree in 2003, followed by a Ph.D. in Medical Biochemistry and Molecular Biology from the University of Turku, Finland, in 2007, where her thesis focused on “Signaling of ErbB4 Isoforms in Cancer.” She was later awarded the Title of Docent in 2015 and became a Specialist Physician in Clinical Oncology and Radiotherapy in 2018. Professionally, Dr. Sundvall serves as a Consultant in Clinical Oncology at Turku University Hospital and a Clinical Lecturer at the Institute of Biomedicine, University of Turku, where she also directs the Cancer Research Unit. Her earlier career includes postdoctoral research at Harvard Medical School under Professor P.P. Pandolfi, where she advanced her expertise in oncogenic signaling and targeted cancer therapies. Her research interests focus on receptor tyrosine kinase signaling, metabolic vulnerabilities in cancer, resistance mechanisms to EGFR-targeting therapies, and precision oncology for breast and prostate cancers. Dr. Sundvall possesses advanced research skills in molecular biology, cell signaling, cancer genomics, and translational medicine, with proficiency in various laboratory and clinical trial methodologies. She has authored over 34 publications in prestigious journals such as PNAS, Cancer Research, Clinical Cancer Research, and Oncogene, contributing key insights into cancer mechanisms and therapeutic resistance. Her numerous honors include the Turku University Foundation Ph.D. Thesis Award and research grants exceeding €1 million from the Research Council of Finland, the Finnish Medical Foundation, and the Sigrid Juselius Foundation. In conclusion, Dr. Sundvall exemplifies excellence in research, teaching, and clinical innovation, with her work significantly advancing the understanding of cancer biology and influencing future directions in precision oncology and patient-centered cancer care worldwide.

Profiles: Scopus | ORCID | LinkedIn

Featured Publications

Sriraman, S., Virtanen, V., Kukkula, A., Toriseva, M., Lumiainen, A., West, G., Poutanen, M., Taimen, P., & Sundvall, M. (2025). Androgen receptor‐mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer. The Journal of Pathology. Advance online publication.

Koskela, S., Pulkkinen, O., Mehmood, A., Kallionpää, R., Birkman, E.-M., Huuhtanen, J., Mustjoki, S., Coupland, S., Aittokallio, T., & Sundvall, M. (2025, July 8). Novel anti-PD1 predictive signature and functional dendritic-cell biomarkers in melanoma identified with systems immunology [Preprint]. Research Square.

Gnjatovic, J., Garces Ibanez, J., Rantala, J., Sundvall, M., Alanne, E., Vaittinen, S., Mattila, P., Jäättelä, M., & Hämälistö, S. (2025, April 29). Patient-derived lymphoma organoids and repurposed drugs: Novel solutions for improved B cell lymphoma treatment [Conference paper].

Hollmén, M., Löyttyniemi, E., Juhanoja, E., Vihinen, P., & Sundvall, M. (2025, February). High comorbidity and tumor proliferation predict survival of localized breast cancer patients after curative surgery: A retrospective analysis of real-world data in Finland. Surgical Oncology, 102(188).

Nissi, L., Tuominen, S., Routila, J., Huusko, T., Ketonen, P., Sundvall, M., Leivo, I., Irjala, H., Minn, H., & Grönroos, T. J. (2024, November). xCT as a predictor for survival in a population‐based cohort of head and neck squamous cell carcinoma. Cancer Medicine.

Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Published on by WSA Awards

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Researcher Award

Medical Director from Exeltis Healthcare | Germany 

Dr. Pedro Antonio Regidor is a dual-national (Spanish and German) medical doctor and scientist with over three decades of clinical and leadership experience in the field of gynecology and obstetrics. He is currently the Medical Director of Exeltis Europe & Global Projects, overseeing pharmaceutical initiatives and innovations in women’s health across international markets. Dr. Regidor is a specialist in gynecological oncology, reproductive medicine, surgical gynecology, and perinatal care, and has performed thousands of complex surgeries and deliveries. His clinical expertise is reinforced by his academic contributions, having earned an MD in 1992 and a PhD in 2000 from the University of Essen. He has held several key roles in prominent German institutions such as the University of Essen, Westfälische Wilhelms-Universität Münster, and Klinikum Osnabrück. In addition, he has served in leadership roles within private medical consultancies and pharmaceutical companies. Dr. Regidor’s career reflects a dynamic integration of patient care, medical research, academic excellence, and corporate strategy. Through his work with Exeltis and affiliations with multiple scientific boards, he continues to shape the future of gynecological healthcare and pharmaceutical development on a global scale.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Regidor’s academic foundation is built on a robust medical and scientific education acquired in Germany. He earned his Doctor of Medicine (MD) on 21 March 1992, with a thesis focused on immunohistochemical detection of progesterone receptors in various tissues. His pursuit of advanced knowledge continued with a PhD in Gynecology and Obstetrics awarded by the University of Essen on 14 April 2000, based on research into peritoneal endometriosis. His studies not only demonstrated academic excellence but also provided the groundwork for his specializations in women’s health. Throughout his educational journey, he gained comprehensive training in multiple sub-disciplines, including endocrine disorders, surgical gynecology, and diagnostic imaging techniques such as mammography and hysterosalpingography. Dr. Regidor also pursued professional licensure in multiple countries, including Germany and Switzerland, reflecting his global perspective and adaptability in medical practice. He earned several professional qualifications between 1995 and 2006, officially recognized as a specialist in gynecology and obstetrics, gynecological endocrinology, reproductive medicine, and gynecological oncology. His academic credentials have empowered him to lead not only in clinical settings but also in the pharmaceutical and medical research sectors, demonstrating a lifelong commitment to education and advancement in medical science.

Professional Experience

Dr. Pedro Antonio Regidor has accumulated over 30 years of diverse professional experience, ranging from university hospitals and private clinics to high-level executive roles in the pharmaceutical industry. He began his medical career as a junior and medical resident at the University of Essen, focusing on gynecological oncology. His international exposure included a residency at Clínica Maternidad Concepción Palacios in Caracas, Venezuela, which enriched his global medical perspective. He later served as Assistant Medical Director in Essen and at Westfälische Wilhelms-Universität Münster, eventually becoming Chief of the Department of Gynecology and Obstetrics at Klinikum Osnabrück. Following years of leading hospital-based services, Dr. Regidor transitioned into private consultancy and pharmaceutical leadership roles. Since 2009, he has been affiliated with Frauenklinik München West and worked in executive medical roles for Velvian Germany GmbH and Exeltis. Currently, he is Medical Director of Exeltis Europe & Global Projects, managing international clinical and product development strategies. His career is distinguished by thousands of complex surgeries, strategic oversight of medical centers, and leadership in multinational pharmaceutical operations. His ability to bridge clinical knowledge with organizational leadership makes him a rare expert in both hands-on patient care and large-scale medical innovation.

Research Interests

Dr. Regidor’s research interests lie primarily in gynecological oncology, reproductive medicine, endocrinology, and women’s health diagnostics and therapeutics. He has a strong academic inclination toward understanding the pathophysiology of endometriosis, as evidenced by his PhD research on immunohistochemical investigations. He is particularly focused on the integration of clinical evidence with pharmacological innovation, developing solutions that address unmet needs in hormone replacement therapy, fertility regulation, and perinatal management. Through his leadership at Exeltis, he also explores new formulations of estrogen and progesterone therapies, especially in menopausal care and contraceptive technologies. Dr. Regidor is deeply invested in the development and validation of clinical protocols for surgical interventions, breast reconstruction, hormone diagnostics, and cancer therapy. He continues to engage in international collaborative research projects, particularly in clinical trials involving women’s hormone treatments and breast cancer. Additionally, he serves on scientific boards and advisory committees that drive research agendas in reproductive endocrinology and gynecological oncology. His work frequently intersects clinical application with scientific innovation, making him a key figure in translational medicine.

Research Skills

Dr. Regidor possesses a highly specialized skill set that encompasses both clinical research and surgical expertise. He is proficient in conducting immunohistochemical analyses, clinical trial coordination, and protocol development. His strong foundation in gynecological diagnostics allows him to interpret laboratory results with precision and apply them directly in surgical and medical decision-making. His surgical record is extensive, with over 7,000 procedures ranging from total laparoscopic hysterectomies to breast reconstructions, demonstrating exceptional hands-on expertise. In research contexts, he is adept at designing clinical studies, interpreting biomedical data, and ensuring ethical compliance across international sites. He has a deep understanding of hormonal pathways, disease modeling, and advanced imaging techniques, including radiological diagnostics for gynecologic applications. Dr. Regidor is also skilled in multilingual communication, enabling him to effectively collaborate on global research initiatives. Furthermore, his involvement with pharmaceutical companies has honed his abilities in regulatory science, medical writing, and strategic development of therapeutic pipelines. His combined skills in surgery, diagnostics, and clinical research make him a versatile asset in both academic and industry settings.

Awards and Honors

Over the course of his distinguished career, Dr. Pedro-Antonio Regidor has received numerous appointments and recognitions reflective of his impact in gynecology and medical leadership. While his career is not defined by traditional academic awards, his leadership roles themselves signify recognition by his peers and institutions. He served as Coordinator and Founding Member of the Breast Center in Münster, a pioneering initiative that contributed to Germany’s breast cancer diagnostic network. His repeated appointments as Medical Director at Velvian Germany GmbH and Exeltis Germany, Europe, and Global Projects further underscore his reputation as a trusted leader in the medical and pharmaceutical sectors. Additionally, he has been entrusted with consultancy roles for companies like Lipocine Inc. (USA) in the field of hormone therapy, showcasing global acknowledgment of his expertise. He holds membership in over ten professional societies, including the German Society for Gynecology and Obstetrics, West German Tumor Center, and scientific advisory boards related to endometriosis and reconstructive surgery. These positions not only validate his contributions but also recognize his ability to drive forward scientific agendas with clinical relevance.

Publications Top Notes

  • Effect over coagulation and fibrinolysis parameters of a prolonged-release contraceptive (2025) – Gynecological Endocrinology – 1 citation.

  • Prevalence of cumulative cardiovascular risk factors among French women of childbearing age: GYNRISK® survey (2025) – Journal of Gynecology Obstetrics and Human Reproduction – 1 citation.

  • Randomised trial comparing bleeding profiles of prolonged vs immediate-release contraceptives (2025) – European Journal of Contraception and Reproductive Health Care – 3 citations.

  • Anti-inflammatory effects of marine oil enriched with SPMs in Post-COVID Syndrome patients (2024) – Biomedicines – 4 citations.

  • Marine oil supplements during pregnancy to prevent preterm delivery (Review).

  • Omega-3 fatty acids and their role in pregnancy complications like preeclampsia and chorioamnionitis (Review)

Conclusion

Dr. Pedro-Antonio Regidor stands out as a multifaceted leader in gynecology, medical research, and pharmaceutical innovation. His extensive clinical experience, combined with a strong academic foundation and strategic leadership in the pharmaceutical industry, positions him uniquely at the intersection of science and healthcare delivery. He has made significant contributions to women’s health through his pioneering surgical interventions, research in reproductive medicine, and development of hormone-based therapies. His roles in clinical practice, academia, and corporate governance reflect a deep commitment to advancing medical science and improving patient care. Dr. Regidor’s work has positively impacted thousands of patients and influenced the direction of therapeutic innovation across Europe and beyond. With ongoing involvement in global projects and advisory boards, he is poised to further shape the landscape of gynecological healthcare and translational research. His career exemplifies excellence, leadership, and a tireless pursuit of medical advancement, making him a highly deserving candidate for recognition in international research and medical awards.

Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assist. Prof. Dr. Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Physical Therapy from Isfahan University of Medical Sciences, Iran

Dr. Tayebeh Roghani is an accomplished Assistant Professor at the Department of Physiotherapy, Faculty of Rehabilitation Sciences, Isfahan University of Medical Sciences, Iran. With over a decade of academic, clinical, and research experience, she has made significant contributions to the field of physiotherapy, especially in the areas of musculoskeletal aging and osteoporosis. Her career has been driven by a deep commitment to improving physical health outcomes for aging populations through evidence-based physiotherapeutic interventions. She has authored numerous peer-reviewed articles, systematic reviews, and book translations. Her scholarly contributions focus primarily on hyperkyphosis, balance, gait, postural control, and back muscle function, with a particular emphasis on older women. Dr. Roghani is also actively engaged in mentoring MSc students and supervising academic research projects, further demonstrating her role in fostering the next generation of rehabilitation scientists. She has participated in local and international congresses, presented both oral and poster presentations, and has acted as a peer reviewer for prestigious scientific journals. Her academic rigor, research productivity, and teaching excellence make her a standout in her field, and she is widely respected for her methodological approach to research and dedication to the advancement of physiotherapy education and practice.

Professional Profile

Education

Dr. Roghani began her academic journey in 2003 at Isfahan University of Medical Sciences, where she earned her Bachelor of Science (B.S) in Physiotherapy in 2007. Building on her foundational knowledge, she pursued her Master of Science (M.Sc.) in Physiotherapy at Tarbiat Modares University, Tehran, from 2008 to 2011. Her graduate research deepened her understanding of therapeutic methods and patient rehabilitation. She later advanced her academic qualifications by obtaining a Ph.D. in Physiotherapy from Shahid Beheshti University of Medical Sciences, Tehran, in 2017. Her doctoral work primarily investigated osteoporosis, aging-related hyperkyphosis, and associated motor control disorders in postmenopausal women. Throughout her academic training, she participated in numerous workshops and specialized courses, including ISI paper writing, systematic reviews, SPSS data analysis, and neurorehabilitation techniques. These academic milestones have equipped her with robust research capabilities and a strong theoretical foundation. Her progressive academic path, from undergraduate to doctoral studies, highlights her sustained commitment to advancing the scientific understanding of physiotherapy and promoting improved clinical interventions. Dr. Roghani’s education is not only comprehensive but also strategically aligned with her research interests and teaching roles, making her an influential academic figure in the rehabilitation sciences.

Professional Experience

Dr. Tayebeh Roghani has cultivated a distinguished professional career as a physiotherapist, academic, and researcher. Currently an Assistant Professor at Isfahan University of Medical Sciences (IUMS), she has played a key role in both clinical education and research supervision. Since 2014, she has taught numerous undergraduate and postgraduate courses, including hospital internships, therapeutic exercise, evidence-based physiotherapy, and electromyography. Her academic appointments span both Shahid Beheshti University of Medical Sciences and IUMS, reflecting her versatility and recognition across major institutions. Beyond teaching, she serves as an examiner for MSc proposals and theses, evaluating research on osteoarthritis, chronic pain, stroke rehabilitation, and more. Dr. Roghani has also contributed extensively to university-approved research projects focusing on back muscle function, hyperkyphosis, and menopause-related musculoskeletal changes. Her active role in departmental planning, curriculum development, and grand rounds further solidifies her academic leadership. Notably, she has reviewed scientific articles for reputed journals such as PLOS One and Osteoporosis International. Her professional trajectory reflects a blend of academic excellence, clinical insight, and research-driven innovation, positioning her as a leader in advancing rehabilitation practices and physiotherapy education in Iran and beyond.

Research Interest

Dr. Roghani’s primary research interests lie at the intersection of aging, musculoskeletal health, and physiotherapeutic intervention. Her research is focused on age-related hyperkyphosis, osteoporosis, motor control, and the physical functioning of older adults. She is particularly interested in understanding how spinal deformities and muscle imbalances influence postural stability, gait, and balance. Her work has extended into randomized controlled exercise trials to evaluate the effectiveness of aerobic and resistance training—both with and without external loading—on improving bone metabolism and physical fitness in postmenopausal women. Another significant area of her research is the assessment and enhancement of back extensor muscle function in individuals with age-related spinal curvature. She also investigates the clinical implications of musculoskeletal variables on abdominal bloating and gait speed in women experiencing menopause. Her approach is both experimental and evidence-based, often involving cross-sectional and comparative designs as well as systematic reviews and meta-analyses. Collaborating with both national and international researchers, she aims to translate clinical observations into scientifically validated treatment approaches. Her research not only adds depth to physiotherapy literature but also contributes to the development of effective, non-invasive interventions for aging populations.

Research Skills

Dr. Tayebeh Roghani brings a diverse set of research skills to the field of physiotherapy and rehabilitation sciences. Her proficiency includes designing and conducting randomized controlled trials, performing systematic reviews, and carrying out meta-analyses. She is well-versed in using statistical software such as SPSS for quantitative data analysis and has experience with MATLAB for modeling and simulation. Dr. Roghani is skilled in both clinical and experimental research methodologies, including biomechanical assessments, electromyography, and gait analysis. She has developed validated instruments to assess static back extensor strength and spinal curvature, enhancing reliability in clinical trials involving older women. Her understanding of hormonal biomarkers and their relationship to physical function adds a multidisciplinary edge to her research. She has also been trained in ethical research practices, data interpretation, and evidence-based protocol development. As a peer reviewer for international journals, she evaluates scientific manuscripts with a keen eye for methodological rigor and clarity. Dr. Roghani’s comprehensive research toolkit enables her to carry out robust investigations that bridge the gap between theory and clinical application, ultimately contributing to improved patient outcomes in musculoskeletal and geriatric rehabilitation.

Awards and Honors

Dr. Tayebeh Roghani has been the recipient of notable academic honors that recognize her commitment to excellence in physiotherapy education and research. During her doctoral studies, she was awarded the Ph.D. Student Distinguished Achievement Award in both the 9th and 10th Shahid Motahari Educational Festivals in 2014 and 2015 respectively. These prestigious awards are given to outstanding students who demonstrate exceptional academic performance, research quality, and educational leadership. The recognition reflects her strong dedication to physiotherapy as a scientific discipline and highlights her early contributions to the field, even before completing her Ph.D. Beyond these accolades, her selection as a peer reviewer for high-impact journals such as PLOS One, Osteoporosis International, and Physiotherapy Theory and Practice indicates professional recognition of her scholarly expertise. These honors, coupled with her institutional project approvals and invited academic roles, affirm her status as a leading academic and a role model within the field of rehabilitation sciences. Dr. Roghani’s career trajectory is marked not just by her achievements but by the consistent recognition of her excellence by peers, mentors, and academic institutions alike.

Conclusion

Dr. Tayebeh Roghani stands out as a dedicated and accomplished scholar whose contributions to the field of physiotherapy have had meaningful impact both in academia and clinical practice. With a strong educational foundation, impressive publication record, and a clear focus on aging-related musculoskeletal conditions, she brings depth, precision, and relevance to her research. Her ability to bridge theoretical knowledge with practical application positions her as a valuable asset in developing innovative rehabilitative approaches. Moreover, her role as a teacher, mentor, and examiner demonstrates her commitment to fostering the next generation of healthcare professionals. She is actively involved in collaborative research and maintains strong ties with institutional and international peers. While she has already achieved much, there remains significant potential for future growth through expanded global collaborations, grant acquisition, and continued interdisciplinary exploration. In summary, Dr. Roghani exemplifies the attributes of an outstanding researcher—rigorous, ethical, collaborative, and visionary. Her sustained efforts make her a highly suitable candidate for the Best Researcher Award, and her ongoing work promises continued advancements in rehabilitation science and physiotherapy for aging populations.

Publications Top Notes

  1. Comparison of Back Extensor Muscle Function in Older Males With and Without Age-Related Hyperkyphosis: A Protocol Study
    Journal: The Scientific Journal of Rehabilitation Medicine, 2025
    Authors: Anahita Vahdati, Hoda Niknam, Tayebeh Roghani

  2. Spinal‐Related Musculoskeletal Determinants of Functional Abdominal Bloating and Distension: A Narrative Review
    Journal: Health Science Reports, 2025
    DOI: 10.1002/hsr2.70976
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Amy Gladin, Wendy B. Katzman, Fateme Bokaee, Peyman Adibi

  3. Associations Between Menopause Status, Spinal-Related Musculoskeletal Variables and Gait Speed in Middle-Aged Females: A Short Report
    Journal: Musculoskeletal Care, 2024
    Authors: Faezeh Fatehi, Tayebeh Roghani, Azam Zafarbakhsh, Amy Gladin, Fateme Bokaee, Najimeh Tarkesh Isfahani, Ibrahim Abdollahpour, Hoda Niknam, Motahar Heidari-Beni, Wendy B. Katzman

  4. Comparison of Postural Balance, Muscle Force and Spinal Posture in Obese Children and Adolescents – A Protocol Study
    Journal: Iranian Journal of Diabetes and Obesity, 2024
    Authors: Fateme Reysy, Fateme Bokaee, Tayebeh Roghani, Grace O’Malley, Najimeh Tarkesh Esfahani, Motahar Heidari Beni, Roya Kelishadi

  5. Investigating the Difference Between Thoracic Kyphosis and Its Mobility in Community-Dwelling Older Men and Women
    Journal: Journal of Modern Rehabilitation, 2024
    Authors: Somayeh Mahmoodiaghdam, Maryam Nodehi, Himan Aryanfar, Tayebeh Roghani, Alireza Akbarzadeh Baghban, Minoo Khalkhali Zavieh

  6. Short and Medium-Term Effects of Kinesio Taping on Proprioception After Anterior Cruciate Ligament Reconstruction
    Journal: The Scientific Journal of Rehabilitation Medicine, 2024
    Authors: Tayebeh Roghani, Hoda Niknam, Mehdi Rezaei, Narges Jahantigh Akbari, Ali Asghar Jame Bozorgi

  7. The Association Between Physical Function and Hyperkyphosis in Older Females: A Systematic Review and Meta-Analysis
    Journal: Journal of Geriatric Physical Therapy, 2024
    Authors: Tayebeh Roghani, Diane D. Allen, Amy Gladin, Alireza Rahimi, Marziyeh Mehrabi, Zahra Sadat Rezaeian, Ziba Farajzadegan, Wendy B. Katzman

  8. The Comparison of Musculoskeletal Variables in Females With and Without Functional Abdominal Bloating: A Protocol Study
    Journal: Journal of Rehabilitation Sciences and Research, 2024
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Mostafa Raisi, Ibrahim Abdollahpour, Fateme Bokaee, Najimeh Tarkesh Isfahani, Seyed Mohsen Mirbod, Motahar Heidari-Beni, Peyman Adibi

Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Mr. Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Gansu Maternal and Child Health Care Hospital (Gansu Provincial Central Hospital), China

Dr. Juncheng Zhang is a highly experienced gynecologist with over 12 years of dedicated service in the field of obstetrics and gynecology. Currently serving as a Gynaecologist-in-charge, he has built a clinical and research career centered around women’s reproductive health, with a strong focus on cancer immunotherapy. His primary academic interest lies in the development of innovative immunotherapeutic treatments for cervical cancer, particularly adoptive cell therapy. Dr. Zhang has recently contributed to scholarly literature through a publication in the International Journal of Gynaecology & Obstetrics, underscoring his commitment to research-driven clinical advancements. Although his citation index and collaborations are still in development, his work presents significant potential for future impact in both academic and clinical communities. Dr. Zhang is recognized for his analytical thinking, patient-centered care, and efforts to bridge clinical practice with medical research. His self-motivation and commitment to continuous learning make him a valuable contributor to the medical field. With further opportunities for research collaborations and publication expansion, Dr. Zhang is on track to become a leading expert in immunotherapy for gynecological cancers. His emerging research profile demonstrates both promise and dedication to improving outcomes for patients affected by cervical cancer.

Professional Profile

Education

Dr. Juncheng Zhang’s educational foundation is rooted in medical science, with specialized training in obstetrics and gynecology. Although specific degree titles and institutions were not mentioned in his nomination form, it is clear that his qualifications have enabled him to serve as an attending physician in a clinical setting for over a decade. Typically, such a career trajectory involves earning a Bachelor of Medicine degree (MBBS or equivalent), followed by a residency or postgraduate specialization in gynecology and obstetrics. His academic background has equipped him with in-depth knowledge in both reproductive health and advanced medical interventions, particularly in the area of oncological gynecology. Dr. Zhang’s continued interest in research further reflects the academic rigor he has maintained throughout his professional development. The progression from medical training to research in immunotherapy suggests that he has received not only clinical training but also exposure to scientific research methodologies. As he continues to publish in indexed journals and engage in specialized research, it is likely that Dr. Zhang is either actively engaged in or planning to pursue further academic qualifications, such as a Master’s or Doctorate in a related field. This combination of clinical and research education forms a strong foundation for his contributions to women’s healthcare.

Professional Experience

Dr. Juncheng Zhang has amassed over 12 years of professional experience in the field of obstetrics and gynecology, currently holding the position of Gynaecologist-in-charge. His clinical responsibilities include managing women’s reproductive health, diagnosing and treating gynecological conditions, and performing both routine and complex procedures. Over the years, he has developed a profound understanding of the physiological and pathological aspects of gynecological diseases. In parallel to his clinical practice, Dr. Zhang has cultivated a strong research interest in cervical cancer, leading him to pursue scientific investigation alongside patient care. His dual role as a physician and a researcher has enabled him to directly translate clinical observations into research questions, fostering a pragmatic and relevant approach to medical research. His professional journey is marked by a transition into cancer immunotherapy, particularly the use of adoptive cell therapies, where he seeks to explore novel treatments for one of the most challenging diseases affecting women. Despite limited experience in industry consultancy or editorial roles, Dr. Zhang’s clinical leadership and emerging research credentials establish him as a dedicated and evolving professional in the medical community. His ongoing publication activity indicates a promising future trajectory, blending clinical excellence with research innovation.

Research Interests

Dr. Zhang’s primary research interests center on cervical cancer immunotherapy, a field that integrates immunology, oncology, and clinical medicine. He is particularly focused on adoptive cell therapy, which involves enhancing the body’s immune response by administering immune cells engineered or activated outside the body. This therapeutic strategy is gaining traction in cancer treatment and holds specific promise for cervical cancer, a disease with considerable global morbidity. His work on the role of CD3 and CD28 in cervical cancer cell proliferation and their impact on peripheral blood mononuclear cell (PBMC) invasion mechanisms reflects a molecular approach to understanding and combating cancer progression. Dr. Zhang aims to contribute to the scientific community by identifying innovative therapeutic pathways that improve treatment outcomes and reduce recurrence. His research bridges the gap between laboratory science and clinical application, contributing valuable knowledge to translational medicine. The use of tumor-infiltrating lymphocytes in treatment design is an especially promising avenue, and Dr. Zhang is actively exploring how this strategy can be tailored to individual patients. His focus aligns with international efforts to enhance targeted therapy and reduce treatment resistance in gynecologic oncology, and he is committed to advancing this research area through publication and potential clinical trials.

Research Skills

Dr. Juncheng Zhang demonstrates a strong command of essential research skills critical for biomedical innovation. His ability to design, execute, and analyze experiments involving immunotherapy mechanisms positions him as a competent translational researcher. He has practical experience in evaluating the roles of immune markers such as CD3 and CD28 in tumor biology, reflecting a solid grasp of molecular biology techniques. Dr. Zhang’s recent publication in an indexed journal illustrates his proficiency in scientific writing and literature synthesis. His knowledge of adoptive cell therapies further underscores familiarity with cutting-edge cancer treatment modalities and laboratory processes involved in cell preparation, expansion, and activation. Additionally, Dr. Zhang appears adept at hypothesis generation based on clinical challenges, a vital research skill that supports the development of impactful investigations. While his exposure to citation metrics and interdisciplinary collaborations may still be developing, the depth of his subject-specific expertise provides a strong foundation for future growth. As he continues to refine his research methodology and expand his publication record, Dr. Zhang is well-positioned to make significant contributions to the field of gynecologic oncology. His integrated skill set allows him to navigate both the clinical and research environments effectively, ensuring that his scientific work remains practically relevant.

Awards and Honors

While Dr. Juncheng Zhang has not listed specific awards or honors in his nomination form, his selection for consideration in the Best Researcher Award itself reflects growing recognition of his contributions to the field of cervical cancer immunotherapy. Emerging researchers often begin their award journey through peer-reviewed publications and conference presentations, milestones Dr. Zhang has started to achieve. His first major publication in a prestigious indexed journal suggests he is gaining visibility in the academic and clinical research communities. As his research matures and gains citation traction, opportunities for awards, fellowships, and research grants will likely follow. In many cases, clinician-researchers such as Dr. Zhang are recognized for bridging the gap between practice and innovation—a commendable achievement in itself. Awards in this domain typically follow impactful clinical trials, translational research breakthroughs, or innovations in patient care. With continued publication, collaborative projects, and deeper involvement in research societies, Dr. Zhang will be well-placed to receive formal honors from medical associations, academic institutions, and healthcare innovation platforms. His trajectory indicates strong potential for future awards as he builds upon his existing foundation of scientific and clinical excellence.

Conclusion

Dr. Juncheng Zhang is a promising clinician-researcher whose dedication to improving women’s healthcare through scientific innovation is clearly evident. With over a decade of experience as a gynecologist, he brings real-world clinical insights into the research laboratory, allowing for impactful, patient-centered investigation. His focused interest in cervical cancer immunotherapy, particularly in adoptive cell therapy, reflects a cutting-edge approach that aligns with global priorities in cancer research. Though his academic portfolio is still in its early stages, his first publication marks a critical step in establishing his presence in the research community. His methodological clarity, clinical depth, and strong motivation make him an ideal candidate for advanced recognition. While areas such as citation impact, professional society involvement, and collaboration are yet to be expanded, the foundations for a successful and influential research career are firmly in place. Continued publication, increased engagement in academic circles, and involvement in translational trials could significantly elevate his profile. In conclusion, Dr. Zhang is a valuable asset to the field of gynecologic oncology, and with the right opportunities and support, he has the potential to emerge as a leading figure in cancer immunotherapy research.

Publications Top Notes

  1. 🩺 Title: A rare case of pregnancy in a type II unicornuate uterus
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Hongfang Li

  2. 🦠 Title: A rare case of squamous cell carcinoma of the ovary
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Jianping Sun, Hongfang Li